BioCentury | Jun 4, 2020
Product Development

With impending Benlysta submission, GSK seeking new paradigm in lupus nephritis treatment

...differently. Furie is chief of the rheumatology division and professor at the Feinstein Institutes at Northwell Health...
BioCentury | Apr 30, 2020
Distillery Therapeutics

Inhibiting an NMDA receptor to reduce lupus neurological symptoms

...Brook University, Stony Brook, N.Y. email: lonnie.wollmuth@stonybrook.edu CONTACT: Betty Diamond, Feinstein Institute for Medical Research, Northwell Health...
BioCentury | Mar 10, 2020
Product Development

COVID-19 update: gaps persist between U.S. test capacity rhetoric, reality; BARDA funds Hologic’s high-throughput assay

...by the University of Washington Virology Lab; 400 by the Gates Foundation; and 40 by Northwell Health...
Items per page:
1 - 3 of 3
BioCentury | Jun 4, 2020
Product Development

With impending Benlysta submission, GSK seeking new paradigm in lupus nephritis treatment

...differently. Furie is chief of the rheumatology division and professor at the Feinstein Institutes at Northwell Health...
BioCentury | Apr 30, 2020
Distillery Therapeutics

Inhibiting an NMDA receptor to reduce lupus neurological symptoms

...Brook University, Stony Brook, N.Y. email: lonnie.wollmuth@stonybrook.edu CONTACT: Betty Diamond, Feinstein Institute for Medical Research, Northwell Health...
BioCentury | Mar 10, 2020
Product Development

COVID-19 update: gaps persist between U.S. test capacity rhetoric, reality; BARDA funds Hologic’s high-throughput assay

...by the University of Washington Virology Lab; 400 by the Gates Foundation; and 40 by Northwell Health...
Items per page:
1 - 3 of 3